Issue 4/2022
Content (22 Articles)
Cancer risk and genotype–phenotype correlation in Japanese patients with Cowden syndrome
Satoshi Teramae, Naoki Muguruma, Koichi Okamoto, Kumiko Oseto, Ryutaro Nishikawa, Takayuki Tanoue, Keiji Hirata, Shunichi Yanai, Takayuki Matsumoto, Seiji Shimizu, Jun Miwa, Yu Sasaki, Kazuo Yashima, Hiroyuki Ohnuma, Yasushi Sato, Yoshitaka Kitayama, Yoshio Ohda, Atsushi Yamauchi, Yoji Sanomura, Kumiko Tanaka, Yoshiaki Kubo, Hideki Ishikawa, Yoshimi Bando, Tomoko Sonoda, Tetsuji Takayama
Male patients with papillary thyroid cancer have a higher risk of extranodal extension
Hu Hei, Bin Zhou, Wenbo Gong, Chen Zheng, Jianwu Qin
Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory malignancy
Mari Tanaka, Natsuko Kawai, Norihiro Yuasa
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024
Satoshi Oizumi, Kei Takamura, Toshiyuki Harada, Motoko Tachihara, Naoto Morikawa, Ryoichi Honda, Satoshi Watanabe, Tetsuhiko Asao, Mamoru Kunisaki, Tatsuro Fukuhara, Rintaro Noro, Eiki Kikuchi, Yasuhiro Tsutani, Toshiyuki Tenma, Kunihiko Kobayashi, Hirotoshi Dosaka-Akita
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
Akio Nakasya, Yuya Hagiwara, Tatsuki Ikoma, Yusuke Kurioka, Toshihiko Matsumoto, Yoshiyuki Yamamoto, Takao Tsuduki, Takeshi Kajiwara, Toshikazu Moriwaki, Tomohiro Nishina, Natsumi Yamashita, Ichinosuke Hyodo
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA
Thomas John, Hiroshi Sakai, Satoshi Ikeda, Ying Cheng, Kazuo Kasahara, Yuki Sato, Yoshiro Nakahara, Masayuki Takeda, Hiroyasu Kaneda, Helong Zhang, Makoto Maemondo, Koichi Minato, Takeshi Hisada, Yuki Misumi, Miyako Satouchi, Katsuyuki Hotta, Ang Li, Abderrahim Oukessou, Shun Lu
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study
Yiqun Han, Yun Wu, Hangcheng Xu, Jiayu Wang, Binghe Xu
Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resection
Mitsuru Yanagaki, Yoshihiro Shirai, Ryoga Hamura, Tomohiko Taniai, Yoshiaki Tanji, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Hiroaki Shiba, Toru Ikegami
Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer
Nobuhito Ito, Kohei Funasaka, Ryoji Miyahara, Kazuhiro Furukawa, Takeshi Yamamura, Takuya Ishikawa, Eizaburo Ohno, Masanao Nakamura, Hiroki Kawashima, Yoshiki Hirooka, Mitsuhiro Fujishiro
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade
Chih-Chieh Ko, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Hao-Jan Lei, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location
Yongle Chen, Zexian Chen, Juanni Huang, Jiancong Hu, Xiaowen He, Ping Lan, Xiaosheng He
Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer
Masato Yamadera, Eiji Shinto, Ken Nagata, Takehiro Shiraishi, Yoshiki Kajiwara, Satsuki Mochizuki, Koichi Okamoto, Yoji Kishi, Hideki Ueno
Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching
Lingkai Xu, Lin Li, Dongkui Xu, Junlan Qiu, Qingting Feng, Tao Wen, Shun Lu, Fang Meng, Xiaochen Shu
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
Takeshi Ujike, Motohide Uemura, Taigo Kato, Koji Hatano, Atsunari Kawashima, Akira Nagahara, Kazutoshi Fujita, Ryoichi Imamura, Norio Nonomura
Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy
Shuichi Morizane, Masashi Honda, Ryutaro Shimizu, Panagiota Tsounapi, Shogo Teraoka, Tetsuya Yumioka, Noriya Yamaguchi, Bunya Kawamoto, Hideto Iwamoto, Katsuya Hikita, Atsushi Takenaka
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer
Hiroki Nasu, Shin Nishio, Jongmyung Park, Teruyuki Yoshimitsu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Kimio Ushijima
Role of adjuvant chemotherapy in patients with localized, undifferentiated pleomorphic sarcoma of soft tissue: a population-based cohort study
Hiroshi Kobayashi, Liuzhe Zhang, Toshihide Hirai, Yusuke Tsuda, Masachika Ikegami, Sakae Tanaka
CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis
Bin Wang, Lifang Yan, Weihong Shi, Han Xie, Ruixiong Chen, Yanqing Shao, Weiguo Liang
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)
Yukari Tsubata, Kana Watanabe, Ryota Saito, Atsushi Nakamura, Hiroshige Yoshioka, Mami Morita, Ryoichi Honda, Nobuhiro Kanaji, Satoshi Oizumi, Daisuke Jingu, Taku Nakagawa, Kensuke Nakazawa, Atsuto Mouri, Susumu Takeuchi, Naoki Furuya, Yuki Akazawa, Kiyotaka Miura, Eiki Ichihara, Makoto Maemondo, Satoshi Morita, Kunihiko Kobayashi, Takeshi Isobe
Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken-Ichirou Morishige, Yutaka Osuga, Nao Suzuki
Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study
Yoichiro Tohi, Takuma Kato, Ryuji Matsumoto, Nobuo Shinohara, Kenichiro Shiga, Akira Yokomizo, Masaki Nakamura, Haruki Kume, Koji Mitsuzuka, Hiroshi Sasaki, Shin Egawa, Masafumi Matsumura, Katsuyoshi Hashine, Junichi Inokuchi, Masatoshi Eto, Haruki Baba, Tomohiko Ichikawa, Hidefumi Kinoshita, Tadashi Matsuda, Yoshiyuki Kakehi, Mikio Sugimoto